Prahlad R. Singh
CEO, President & DirectorDr. Prahlad R. Singh, Ph.D. has been the Chief Executive Officer of Revvity, Inc. (formerly known as PerkinElmer, Inc.) since December 30, 2019. Dr. Singh served as the Chairman of the Supervisory Board at EUROIMMUN Medizinische Labordiagnostika AG until 2023. He serves as Director of Revvity, Inc. (formerly known as PerkinElmer, Inc.) since August 21, 2019. He serves as an independent Director at Amphenol Corporation since January 12, 2023. He has been President at Revvity, Inc. (formerly known as PerkinElmer, Inc.) since January 1, 2019. He had been Chief Operating Officer at Revvity, Inc. (formerly known as PerkinElmer, Inc.) since January 1, 2019 until December 2019. He was Executive Vice President since March 2018 to January 1, 2019 and President of Diagnostics business at Revvity, Inc. (formerly known as PerkinElmer, Inc.) from May 2014 to January 1, 2019 and was its Senior Vice President from October 03, 2016 to March 2018. He has been the President of Diagnostics at PerkinElmer LAS (Germany) GmbH since May 2014 and also has been its Senior Vice President since September 2016. Prior to joining PerkinElmer, he served as Global General Manager of GE Healthcare's Women's Health Business from 2012 to 2014. He held worldwide responsibility for GE Healthcare?s Mammography and Bone Densitometry businesses. He served senior executive level roles in Strategy, Business Development and M&A at both GE and Philips Healthcare from 2011 to 2012. From 1995 to 2007, he served leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol Myers Squibb Medical Imaging which included managing the Asia Pacific and Middle East region. He also currently serves on the Board of Directors of the Analytical, Life Sciences & Diagnostics Association (ALDA). He has vast global leadership experience. His technical work resulted in 35 publications in referred journals and fourteen global patents. His research work has resulted in several issued patents and publications in peer reviewed journals. He is a member of the Massachusetts General Hospital President’s Council. Dr. Singh holds a B.S. from Wilson College, Mumbai, India and a Ph.D. in chemistry from the University of Missouri-Columbia and an MBA from Northeastern University.
Positions
- Company NameRevvity, Inc.Stock CodeRVTYPositionCEO, President & DirectorColleagues
- APAlexis Platon MichasIndependent Non-Executive Chairman
- MKMaxwell KrakowiakSenior VP & CFO
- TSTajinder S. VohraSenior Vice President of Global Operations
- JSJoel S. GoldbergSenior VP of Administration, General Counsel & Secretary
- MVMiriame VictorSenior Vice President & Chief Business Officer
- PBPeter BarrettIndependent Director
- SRSamuel R. ChapinIndependent Director
- PWPascale WitzIndependent Director
